Please to be named a 2021 Castle Connolly Top Doctor: …
[ad_1] Please to be named a 2021 Castle Connolly Top Doctor: https://t.co/6qltclAxYs [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
Month: September 2021
Just published: “Genetics of Diabetic Retinopathy, a Leading Cause of Irreversib…
[ad_1] Just published: “Genetics of Diabetic Retinopathy, a Leading Cause of Irreversible Blindness in the Industrialized World” #eye #retina #diabetes #diabeticretinopathy #gene #genetics https://t.co/6mbnVXMe5w via @MDPIOpenAccess [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
Looking forward to Tuesday’s (9/21) workshop, “Showcasing the Translatability of…
[ad_1]
Looking forward to Tuesday’s (9/21) workshop, “Showcasing the Translatability of Suprachoroidal Delivery” at https://t.co/wh9l5M7eTe The 2nd Annual Conference on “Gene Therapy for Ophthalmic Disorders”
#eye #retina #genetherapy #suprachoroidal #biotech https://t.co/pcG2CLMXZf
[ad_2]
Source by Thomas Ciulla, MD, MBA
There has been increased interest in #suprachoroidal #genetherapy and our recent…
[ad_1] There has been increased interest in #suprachoroidal #genetherapy and our recent paper…. https://t.co/XXzkOOg6sM [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
Just published: “Challenges of cost-effectiveness analyses of novel therapeutic…
[ad_1] Just published: https://t.co/J6DVFiHmqX “Challenges of cost-effectiveness analyses of novel therapeutics for Inherited Retinal Diseases” While the current #healthcare system may appropriately value chronically administered therapies, it may not properly appraise #GeneTherapy… https://t.co/5qedMXTz9f [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
RT @ThomasCiullaMD: Given recent clinical trial results in geographic atrophy/dr…
[ad_1]
RT @ThomasCiullaMD: Given recent clinical trial results in geographic atrophy/dry AMD, there has been great interest in our review of compl…
[ad_2]
Source by Thomas Ciulla, MD, MBA
RT @RevOphth: Therapeutics in the Suprachoroidal Space — A look at different ap…
[ad_1] RT @RevOphth: Therapeutics in the Suprachoroidal Space — A look at different approaches companies are taking to make use of this unique as… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
Thanks to Keith Barton, Kuldev Singh, Bart Leroy & Dominik Fischer for inviting …
[ad_1] Thanks to Keith Barton, Kuldev Singh, Bart Leroy & Dominik Fischer for inviting me to participate in the Ophthalmology Futures European Retina Forum 2021, featuring interesting panel sessions & presentations on therapeutic innovation! #eyes #retina #retinaspecialist #biotech https://t.co/qEUiQYX1tk [ad_2] Source by Thomas Ciulla, MD, …
Honored to be interviewed for this piece on the Business of Medicine MBA, an uni…
[ad_1]
Honored to be interviewed for this piece on the Business of Medicine MBA, an unique program for physicians, offered by Indiana University’s Kelley School of Business, a highly ranked MBA program… https://t.co/VOqnkBnSpf
[ad_2]
Source by Thomas Ciulla, MD, MBA